Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

10/08/2018 09:00

Aug 10 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            13 mln              200 mln                    
                 (-93.3 pct)                                      
  Operating     loss 712 mln        loss 593 mln                  
  Recurring     loss 717 mln        loss 590 mln                  
  Net           loss 647 mln        loss 568 mln                  
  EPS           loss 4.40 yen       loss 3.86 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T